Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $294,185 - $352,805
2,127 Added 5.39%
41,561 $6.72 Million
Q3 2022

Oct 20, 2022

BUY
$134.21 - $153.93 $348,946 - $400,218
2,600 Added 7.06%
39,434 $5.29 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $520,616 - $661,873
3,783 Added 11.45%
36,834 $5.64 Million
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $4.38 Million - $5.43 Million
-33,178 Reduced 50.1%
33,051 $5.36 Million
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $434,984 - $550,380
4,049 Added 6.51%
66,229 $8.97 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $636,059 - $722,022
5,978 Added 10.64%
62,180 $6.71 Million
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $738,258 - $822,462
7,017 Added 14.27%
56,202 $6.33 Million
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $192,937 - $212,401
1,886 Added 3.99%
49,185 $5.32 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $346,589 - $467,933
4,306 Added 10.02%
47,299 $5.07 Million
Q3 2020

Nov 04, 2020

BUY
$85.91 - $100.83 $1.62 Million - $1.9 Million
18,847 Added 78.05%
42,993 $3.77 Million
Q2 2020

Aug 12, 2020

SELL
$73.37 - $98.18 $1.75 Million - $2.34 Million
-23,833 Reduced 49.67%
24,146 $2.37 Million
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $88,623 - $134,363
-1,374 Reduced 2.78%
47,979 $3.66 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $165,610 - $207,214
-2,296 Reduced 4.45%
49,353 $4.56 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $316,915 - $381,023
5,032 Added 10.79%
51,649 $3.91 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $1.46 Million - $1.87 Million
22,295 Added 91.67%
46,617 $3.39 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $906,934 - $1.07 Million
11,757 Added 93.57%
24,322 $1.96 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $80,574 - $99,370
1,035 Added 8.98%
12,565 $1.16 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $42,854 - $47,640
-482 Reduced 4.01%
11,530 $1.09 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $26,574 - $31,444
-296 Reduced 2.4%
12,012 $0
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $958,652 - $1.28 Million
-10,419 Reduced 45.84%
12,308 $1.17 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $1.06 Million - $1.16 Million
-11,860 Reduced 34.29%
22,727 $2.2 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $150,526 - $192,269
2,155 Added 6.64%
34,587 $3.07 Million
Q2 2017

Aug 08, 2017

BUY
N/A
32,432
32,432 $2.35 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Argi Investment Services, LLC Portfolio

Follow Argi Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argi Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argi Investment Services, LLC with notifications on news.